Daniel P Cahill

29PUBLICATIONS
273CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Molecular targetsComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Aug 05, 2026
Vorasidenib improves response to subsequent chemoradiation in a genetically engineered mouse model of IDH-mutant glioma.

|Jun 12, 2026
IDH1-Associated m6A Methylation Is Linked to Transcriptomic Heterogeneity in Glioma.

|Mar 30, 2026
Effects of short- and long-term mutant IDH1 inhibition on radiosensitivity across genetically diverse patient-derived IDH1-mutant glioma cells.

Yosuke Kitagawa, Logan D Muzyka, Ami Kobayashi

|May 29, 2025
Clinical, molecular, and radiological predictors of prognosis in newly diagnosed astrocytoma, IDH-mutant, WHO grade 4.

Aleksandra B Lasica, Zhou Lan, Julie J Miller

|Feb 06, 2025
Ivosidenib for the treatment of IDH1-mutant glioma, grades 2-4: Tolerability, predictors of response, and outcomes.

Tyler A Lanman, Gilbert Youssef, Raymond Huang

|Jan 09, 2025
A hitchhiker's guide to cerebrospinal fluid biomarkers for neuro-oncology.

Cecile Riviere-Cazaux, Michael B Keough, Jeffrey A Zuccato

Pageof 5

Frequent Collaborators

4 joint publications

Philipp Karschnia

4 joint publications

Julie J Miller

4 joint publications

Hiroaki Wakimoto

3 joint publications

Joerg-Christian Tonn